XP invests in Brazilian biotech SuperBac
The investment arm of Brazilian bank XP has relied on Mattos Filho in São Paulo to invest 300 million reais (US$62 million) in Brazilian biotech company SuperBac.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.